Why the study?
Do selective serotonin reuptake inhibitors (SSRIs) increase QTc prolongation compared to placebo or TCAs in adult patients?
Population
4,292 adult patients from 16 prospective controlled studies (25 distinct data subsets)
Comparison
Selective serotonin reuptake inhibitors as a class vs Placebo or tricyclic antidepressants (TCAs)
Design
Meta-analysis
Authors
Loading...
Supports QTc monitoring with higher-dose SSRIs in at-risk patients; extends evidence by quantifying effects versus TCAs.
Do selective serotonin reuptake inhibitors (SSRIs) increase QTc prolongation compared to placebo or TCAs in adult patients?
SSRIs are associated with a modest, dose-dependent increase in the QTc interval compared to placebo, with citalopram causing more prolongation than other SSRIs, though the overall effect is smaller than that of TCAs.
Beach et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: